Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010

The Lancet

Volumn 382, Issue 9904, 2013, Pages 1575-1586

  Whiteford, Harvey A ^a   Degenhardt, Louisa ^b,c   Rehm, Jürgen ^d,e   Baxter, Amanda J ^a   Ferrari, Alize J ^a   Erskine, Holly E ^a   Charlson, Fiona J ^a   Norman, Rosana E ^a   Flaxman, Abraham D ^f   Johns, Nicole ^f   Burstein, Roy ^f   Murray, Christopher J L ^f   Vos, Theo ^f  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ADOLESCENT; ADULT; AGED; AGING; ALCOHOL USE DISORDER; ANXIETY DISORDER; ARTICLE; AUTISM; BEHAVIOR DISORDER; BIPOLAR DISORDER; CAUSE OF DEATH; CHILD; COMMUNITY; COMORBIDITY; DEPRESSION; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; DRUG DEPENDENCE; EATING DISORDER; FEMALE; GLOBAL BURDEN; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POPULATION GROWTH; PREMATURE MORTALITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; SCHOOL CHILD; STRESS; SUBSTANCE ABUSE; YEARS LIVED WITH DISABILITY; YEARS OF LIFE LOST TO PREMATURE MORTALITY;

EID: 84887259083     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61611-6     Document Type: Article

References (77)

1. Degenhardt L, Whiteford H, Hall W, Vos T. Estimating the burden of disease attributable to illicit drug use and mental disorders: what is 'Global Burden of Disease 2005' and why does it matter? Addiction 2009; 104: 1466-71.
2. Ustün TB. The global burden of mental disorders. Am J Public Health 1999; 89: 1315-18.
3. World Bank. World Development Report 1993. Investing in health: world development indicators. New York: World Bank, 1993.
4. Patel V, Garrison P, de Jesus Mari J, Minas H, Prince M, Saxena S, and the Advisory group of the Movement for Global Mental Health. The Lancet's series on global mental health: 1 year on. Lancet 2008; 372: 1354-57.
5. Murray CJ, Lopez AD. Quantifying disability: data, methods and results. Bull World Health Organ 1994; 72: 481-94.
6. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998; 4: 1241-43.
7. Mathers CD, Stein C, Ma Fat D, et al. Global Burden of Disease 2000: version 2 methods and results. Geneva: World Health Organization, 2002.
8. WHO. The global burden of disease: 2004 update. Geneva: World Health Organization, 2008.
9. Murray CJL, Lopez AD, eds. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996.
10. Murray CJL, Lopez AD, Black R, et al. Global burden of disease 2005: call for collaborators. Lancet 2007; 370: 109-10.
11. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223.
12. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-60.
13. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
14. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2129-43.
15. Salomon JA, Wang H, Freeman MK, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012; 380: 2144-62.
16. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-96.
17. Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2071-94.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR), 4th text revision edn. Washington, DC: American Psychiatric Association, 2000.
19. WHO. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization, 1993.
20. Ferrari AJ, Saha S, McGrath JJ, et al. Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study. Popul Health Metr 2012; 10: 16.
21. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
22. Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med 2013; 43: 897-910.
23. Bucello C, Degenhardt L, Calabria B, et al. What do we know about the extent of cocaine use and dependence? Results of a global systematic review. Sydney: National Drug and Alcohol Research Centre, University of NSW, 2010.
24. Calabria B, Degenhardt L, Briegleb C, et al. Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence. Addict Behav 2010; 35: 741-49.
25. Calabria B, Degenhardt L, Hall W, Lynskey M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev 2010; 29: 318-30.
26. Calabria B, Degenhardt L, Nelson P, et al. What do we know about the extent of cannabis use and dependence? Results of a global systematic review. Sydney: National Drug and Alcohol Research Centre, University of NSW, 2010.
27. Degenhardt L, Bucello C, Calabria B, et al, and the GBD illicit drug use writing group. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 2011; 117: 85-101.
28. Degenhardt L, Calabria B, Nelson P, et al. What do we know about the extent of amphetamine use and dependence? Results of a global systematic review Sydney: National Drug and Alcohol Research Centre, University of NSW, 2010.
29. Degenhardt L, Singleton J, Calabria B, et al. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend 2011; 113: 88-95.
30. Ferrari AJ, Baxter AJ, Whiteford HA. A systematic review of the global distribution and availability of prevalence data for bipolar disorder. J Affect Disord 2011; 134: 1-13.
31. Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med 2013; 43: 471-81.
32. Nelson P, McLaren J, Degenhardt L, et al. What do we know about the extent of heroin and other opioid use and dependence? Results of a global systematic review. Sydney: National Drug and Alcohol Research Centre, University of NSW, 2010.
33. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164: 942-48.
34. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005; 2: e141.
35. Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Degenhardt L. How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010? Curr Opin Psychiatry 2013; 26: 376-83.
36. Baxter AJ, Patton G, Scott KM, Degenhardt L, Whiteford HA. Global epidemiology of mental disorders: what are we missing? PLoS ONE 2013; 8: e65514.
37. Flaxman AD, Vos T, Murray CJL, eds. An integrative metaregression framework for descriptive epidemiology. Seattle: University of Washington Press, 2013.
38. Ezpeleta L, Keeler G, Erkanli A, Costello EJ, Angold A. Epidemiology of psychiatric disability in childhood and adolescence. J Child Psychol Psychiatry 2001; 42: 901-14.
39. Agency for Healthcare Research and Quality. United states medical expenditure panel survey 2000-2009. Rockville, USA: Agency for Healthcare Research and Quality, 2009.
40. US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism. National epidemiologic survey on alcohol and related conditions wave 1 and wave 2. Bethesda, MD: National Institutes of Health, 2006.
41. Australian Bureau of Statistics. Mental health and wellbeing: profile of adults, Australia 1997. Canberra, Australia: Australian Bureau of Statistics, 1998.
42. Schopflocher DP, Tobias M. What difference does dependent comorbidity make in burden of disease studies? A survey analysis and simulation. Global Health Metrics and Evaluation. Seattle, USA. Lancet 2013; 381 (suppl 2): S130.
43. Zaridze D, Maximovitch D, Lazarev A, et al. Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies. Int J Epidemiol 2009; 38: 143-53.
44. WHO. Age standardization of rates: a new WHO standard. http://www.who.int/healthinfo/paper31.pdf (accessed Aug 7, 2013).
45. Ferrari AJ, Charlson FJ, Norman R, et al. The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS One 2013; 8: 1-14.
46. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; published online August 28. http://dx.doi.org/10.1016/S0140-6736(13)61530-5.
47. United Nations. World population prospects - the 2010 revision. New York: United Nations, 2011.
48. Simpson KR, Meadows GN, Frances AJ, Patten SB. Is mental health in the Canadian population changing over time? Can J Psychiatry 2012; 57: 324-31.
49. WHO. The world health report, 2000. Health systems: improving performance. Geneva: World Health Organization, 2000.
50. Vos T, Mathers CD. The burden of mental disorders: a comparison of methods between the Australian burden of disease studies and the Global Burden of Disease study. Bull World Health Organ 2000; 78: 427-38.
51. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The global economic burden of non-communicable diseases, 2011. http://www3.eforum.org/docs/WEF- Harvard-HE-GlobalEconomicBurdenNonCommunicableDiseases-2011.pdf (accessed Dec 3, 2012)
52. Mathers BM, Degenhardt L, Ali H, et al, and the 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010; 375: 1014-28.
53. Wang PS, Aguilar-Gaxiola S, Alonso J, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007; 370: 841-50.
54. Rehm J, Shield KD, Gmel G, Rehm MX, Frick U. Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol 2013; 23: 89-97.
55. Wang PS, Angermeyer M, Borges G, et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007; 6: 177-85.
56. Saxena S, Thornicroft G, Knapp M, Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet 2007; 370: 878-89.
57. Kleinman A. Global mental health: a failure of humanity. Lancet 2009; 374: 603-04.
58. WHO. Mental health atlas 2011. Geneva: World Health Organisation, 2011.
59. Chisholm D, Lund C, Saxena S. Cost of scaling up mental healthcare in low- and middle-income countries. Br J Psychiatry 2007; 191: 528-35.
60. Patel V, Araya R, Chatterjee S, et al. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 2007; 370: 991-1005.
61. Patel V, Simon G, Chowdhary N, Kaaya S, Araya R. Packages of care for depression in low- and middle-income countries. PLoS Med 2009; 6: e1000159.
62. Tol WA, Barbui C, Galappatti A, et al. Mental health and psychosocial support in humanitarian settings: linking practice and research. Lancet 2011; 378: 1581-91.
63. Chisholm D, Saxena S. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012; 344: e609.
64. Chisholm D, Sanderson K, Ayuso-Mateos JL, Saxena S. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 2004; 184: 393-403.
65. Saraceno B, van Ommeren M, Batniji R, et al. Barriers to improvement of mental health services in low-income and middle-income countries. Lancet 2007; 370: 1164-74.
66. Eaton J, McCay L, Semrau M, et al. Scale up of services for mental health in low-income and middle-income countries. Lancet 2011; 378: 1592-603.
67. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851-58.
68. Scott D, Happell B. The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness. Issues Ment Health Nurs 2011; 32: 589-97.
69. Ngo VK, Rubinstein A, Ganju V, et al. Grand challenges: integrating mental health care into the non-communicable disease agenda. PLoS Med 2013; 10: e1001443.
70. Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 2004; 184: 526-33.
71. Kessler RC, Ustun TB, eds. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press, 2008.
72. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-28.
73. Li Z, Page A, Martin G, Taylor R. Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review. Soc Sci Med 2011; 72: 608-16.
74. Yoshimasu K, Kiyohara C, Miyashita K, and the Stress Research Group of the Japanese Society for Hygiene. Suicidal risk factors and completed suicide: meta-analyses based on psychological autopsy studies. Environ Health Prev Med 2008; 13: 243-56.
75. Li Z, Page A, Martin G, Taylor R. Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review. Soc Sci Med 2011 72: 608-16.
76. Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet 2009; 373: 2041-53.
77. Chang SM, Hahm BJ, Lee JY, et al. Cross-national difference in the prevalence of depression caused by the diagnostic threshold. J Affect Disord 2008; 106: 159-67.